These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
271 related items for PubMed ID: 8157967
1. A disease-related epitope of Torpedo acetylcholine receptor. Residues involved in I-Ab binding, self-nonself discrimination, and TCR antagonism. Wall KA, Hu JY, Currier P, Southwood S, Sette A, Infante AJ. J Immunol; 1994 May 01; 152(9):4526-36. PubMed ID: 8157967 [Abstract] [Full Text] [Related]
2. Determinant selection in murine experimental autoimmune myasthenia gravis. Effect of the bm12 mutation on T cell recognition of acetylcholine receptor epitopes. Infante AJ, Thompson PA, Krolick KA, Wall KA. J Immunol; 1991 May 01; 146(9):2977-82. PubMed ID: 1707927 [Abstract] [Full Text] [Related]
3. Inhibition of experimental autoimmune myasthenia gravis by major histocompatibility complex class II competitor peptides results not only in a suppressed but also in an altered immune response. Wauben MH, Hoedemaekers AC, Graus YM, Wagenaar JP, van Eden W, de Baets MH. Eur J Immunol; 1996 Dec 01; 26(12):2866-75. PubMed ID: 8977279 [Abstract] [Full Text] [Related]
4. Autoimmune responses against acetylcholine receptor: T and B cell collaboration and manipulation by synthetic peptides. Atassi MZ, Oshima M. Crit Rev Immunol; 1997 Dec 01; 17(5-6):481-95. PubMed ID: 9419435 [Abstract] [Full Text] [Related]
5. On the initial trigger of myasthenia gravis and suppression of the disease by antibodies against the MHC peptide region involved in the presentation of a pathogenic T-cell epitope. Atassi MZ, Oshima M, Deitiker P. Crit Rev Immunol; 2001 Dec 01; 21(1-3):1-27. PubMed ID: 11642597 [Abstract] [Full Text] [Related]
8. The I-Abm12 mutation, which confers resistance to experimental myasthenia gravis, drastically affects the epitope repertoire of murine CD4+ cells sensitized to nicotinic acetylcholine receptor. Bellone M, Ostlie N, Lei SJ, Wu XD, Conti-Tronconi BM. J Immunol; 1991 Sep 01; 147(5):1484-91. PubMed ID: 1715360 [Abstract] [Full Text] [Related]
9. B-cell activation in vitro by helper T cells specific to region alpha 146-162 of Torpedo californica nicotinic acetylcholine receptor. Rosenberg JS, Oshima M, Atassi MZ. J Immunol; 1996 Oct 01; 157(7):3192-9. PubMed ID: 8816433 [Abstract] [Full Text] [Related]
10. T cell receptor transgenic mice recognizing the immunodominant epitope of the Torpedo californica acetylcholine receptor. Lobito AA, Yang B, Lopes MF, Miagkov A, Adams RN, Palardy GR, Johnson MM, McFarland HI, Recher M, Drachman DB, Lenardo MJ. Eur J Immunol; 2002 Jul 01; 32(7):2055-67. PubMed ID: 12115627 [Abstract] [Full Text] [Related]
11. Structural analysis of the interaction of apamin with Ia and its recognition by Ad- or Ab-restricted mouse T cells. Regnier-Vigouroux A, Ceard B, Van Rietschoten J, Granier C, Pierres M. J Immunol; 1989 Nov 15; 143(10):3167-74. PubMed ID: 2478620 [Abstract] [Full Text] [Related]
12. Unique T cell antagonist properties of the exact self-correlate of a peptide antigen revealed by self-substitution of non-self-positions in the peptide sequence. Schountz T, Kasselman JP, Ford SR, Murray JS. Cell Immunol; 1996 Mar 15; 168(2):193-200. PubMed ID: 8640865 [Abstract] [Full Text] [Related]
13. Elucidation and role of critical residues of immunodominant peptide associated with T cell-mediated parasitic disease. Hernandez HJ, Stadecker MJ. J Immunol; 1999 Oct 01; 163(7):3877-82. PubMed ID: 10490987 [Abstract] [Full Text] [Related]
18. Specificity of the T cell immune response to acetylcholine receptor in experimental autoimmune myasthenia gravis. Response to subunits and synthetic peptides. Fujii Y, Lindstrom J. J Immunol; 1988 Mar 15; 140(6):1830-7. PubMed ID: 2450133 [Abstract] [Full Text] [Related]